Clinical application of liquid biopsy based on circulating tumor DNA in non-small cell lung cancer

Clinical application of liquid biopsy based on circulating tumor DNA in non-small cell lung cancer

Lung cancer is a widely occurring and deadly malignancy, with high prevalence rates in China and across the globe. Specifically, non-small cell lung cancer (NSCLC) represents about 85% of all lung cancer cases. The 5-year disease-free survival rate after surgery for stage IB-IIIB NSCLC patients (dis...

Full description

Bibliographic Details
Main Authors: Liu Xin, Yang Yue, Ren Zihan, Cui Youbin, Lu Tianyu, Wang Rui
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Physiology
Subjects:
liquid biopsy
non-small cell lung cancer
early diagnosis
prognosis
recurrence
adjuvant therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fphys.2023.1200124/full

Internet

https://www.frontiersin.org/articles/10.3389/fphys.2023.1200124/full

Similar Items